TEL
+ 86-21-6420 0566
Краткое описание:
4-Chloro-7-toluenesulfonyl-7H-pyrrolo[2,3-D]pyrimidine (CAS No. 479633-63-1) is a compound with the molecular formula C13H10ClN3O2S and a molecular weight of 30...
4-Chloro-7-toluenesulfonyl-7H-pyrrolo[2,3-D]pyrimidine (CAS No. 479633-63-1) is a compound with the molecular formula C13H10ClN3O2S and a molecular weight of 307.76 g/mol. It is primarily utilized as a pharmaceutical intermediate in the synthesis of selective Janus kinase 3 inhibitors (JAK3) and immunosuppressive drugs, such as tofacitinib. The compound’s structure features a substituted pyrrole ring and a toluene sulfonyl group, which may confer unique chemical properties and reactivity.
In drug development, this intermediate may undergo multi-step organic synthesis reactions, such as substitution and condensation, to introduce various pharmacophoric groups, thereby generating drug candidates with therapeutic potential. Although direct pharmacological data on this compound are currently limited, its role as a pharmaceutical intermediate suggests that the final product may possess immunosuppressive activity, particularly for the treatment of inflammatory diseases. Research on this compound in the fields of chemical synthesis and drug discovery continues, highlighting its potential applications in the pharmaceutical industry. Additionally, it is used as an impurity control in biochemical studies and for drug declaration testing.
Объект | Подробнее |
---|---|
Номер по CAS | 479633-63-1 |
Молекулярная формула | C13H10ClN3O2S |
Молекулярная масса | X |
Внешний вид | White to orange to green powder or crystals |
чистота | ≥ 98% |
Процесс подачи заявки | Pharmaceutical intermediate, used in the synthesis of selective Janus kinase 3 inhibitors (JAK3) and immunosuppressive drugs, such as tofacitinib; impurity control in biochemical studies; drug declaration testing |
Особенности структуры | Substituted pyrrole ring, toluene sulfonyl group |
Синтез | Multi-step organic synthesis reactions, such as substitution, condensation, etc. Involves reaction of 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine with p-toluenesulfonyl chloride under specific conditions |
Фармакологическая активность | Data currently limited, but the final product may have immunosuppressive activity, particularly for the treatment of inflammatory diseases |
Статус исследования | Изучал химический синтез и разработку лекарственных препаратов с потенциальным применением в фармацевтической промышленности. |
Физические свойства | Melting Point: 145.0 to 149.0 °C, Boiling Point: 505.3±60.0 °C, Density: 1.49 g/cm³, Solubility: Slightly soluble in chloroform and DMSO, pKa: 1.73±0.30 |
,Отказ от ответственности: Вышеуказанный контент предназначен только для справки и общения среди инсайдеров отрасли и не гарантирует его точность или полноту. Согласно соответствующим законам и правилам, а также правилам этого веб-сайта, подразделения или лица, которые покупают соответствующие товары, должны получить действительные квалификации и условия квалификации.